Dal­cor taps new CEO Fouzia Laghris­si-Th­ode as piv­otal PhI­II looms; Kel­ly Mar­tin set­tles in at No­van; Ed­ward Stew­art takes over Com­mense

As­traZeneca vet Fouzia Laghris­si-Th­ode will be lead­ing Dal­Cor Phar­ma­ceu­ti­cals through pa­tient en­roll­ment in­to its piv­otal Phase …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.